MHRA positive opinion for avelumab as bladder cancer first-line maintenance treatment

UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for avelumab as first-line...
Novo Nordisk announces first oral tablet to treat type 2 diabetes

Novo Nordisk announces new oral treatment for type 2 diabetes

Novo Nordisk has announced that Rybelsus® (semaglutide tablets), the world’s first and only oral GLP1-RA treatment for type 2 diabetes (T2D), is now available...
Image of white lungs on green background to show EU approves Imfinzi for extensive-stage small cell lung cancer

EU approves Imfinzi for extensive-stage small cell lung cancer

AstraZeneca has announced that the EU has approved Imfinzi (durvalumab) for the 1st-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination...
Image of the world with different location markers joined by dotted lines to show BIVDA joins Trade Advisory Group on Life Sciences

BIVDA joins Trade Advisory Group on Life Sciences

The British In Vitro Diagnostic Association has joined the new trade advisory group on life sciences. International Trade Secretary, Liz Truss, has launched 11 new...
Image of three people sat around a table shaped like a tablet to show EC approves Kaftrio® in combination to treat cystic fibrosis

EC approves Kaftrio® in combination to treat cystic fibrosis

The European Commission (EC) has approved Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in combination with Ivacaftor to treat cystic fibrosis in people aged 12 and older. Vertex Pharmaceuticals announced...
Image of two hands shaking through laptop screens under a contract being signed by two people to show NICE recommends new combination treatment for some lymphoma patients

NICE recommends new combination treatment for some lymphoma patients

NICE has recommended a new combination treatment for some lymphoma patients meaning that hundreds of people will benefit. The new draft guidance published by NICE...
Image of a hand signing a contract to show Sanofi to acquire Principia Biopharma

Sanofi to acquire Principia Biopharma

Sanofi has announced that it is to acquire Principia Biopharma further strengthening its core R&D areas of autoimmune and allergic diseases. Sanofi and Principia Biopharma...
Image of coronavirus and a syringe to show AstraZeneca and European Commission COVID-19 vaccine agreement

AstraZeneca and European Commission COVID-19 vaccine agreement

AstraZeneca has concluded an agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine. This is...
Image of two heads conversing through text bubbles with light bulbs, question marks and cogs to show QBiotics and MSD collaborate on unresectable melanoma

QBiotics and MSD collaborate on unresectable melanoma

QBiotics Group Limited, a life sciences company developing novel anticancer and wound healing pharmaceuticals, has entered into an agreement with MSD to evaluate use...
Image of a magnifying glass held over covid virus to show 'One Million' study to monitor safety and effectiveness of COVID-19 vaccines

‘One Million’ study to monitor COVID-19 vaccine safety and effectiveness

A UK consortium has announced plans for a 'One Million' Post-Authorisation Study to monitor the safety and effectiveness of the COVID-19 vaccine in real-life...

Latest articles

Partnership announced to fight against counterfeit drugs

Partnership announced to fight against counterfeit drugs

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a contract and pen to show WAYLIVRA ▼® (volanesorsen) for FCS to be available on the NHS in England

WAYLIVRA▼® (volanesorsen) for FCS to be available on the NHS in England

The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for WAYLIVRA▼® (volanesorsen), the first and only therapy for adults...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a number of blocks and levels with different icons including magnifying glass, target, steps and graphs to show Coronavirus clinical research brought together in free information centre

Understanding the role of the MSL

Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription